chrisvoncsefalvay/vaers-outcomes huggingface dataset:
To summarize our conversation, you stated that you received the second Pfizer vaccine on 3/4/21.  Three days later, on 3/7/21, you began to have fatigue, shortness of breath, dizziness and chest pressure. Because all symptoms continued for 24 hours, on the evening of 3/8/21, you took yourself to the Emergency Department.  Your ER work-up included a CXR (negative), an EKG (showing a left bundle branch block), serum bloodwork (negative for MI), however, the D-dimer and spiral CT were both positive for a pulmonary emboli (i.e. a blood clot in your lungs).  You were admitted to the hospital and started on the blood thinner, Eliquis.  During your 3-day hospital stay, your work-up also included a bilateral lower extremity Doppler study (negative) and an echocardiogram (showing left ventricular hypertrophy).  You were discharged on all of your previously prescribed medications (see list below), except for the fish oil.  You were also started on Eliquis.  Since discharge, you have followed up with your PCP and have been referred to a cardiologist and pulmonologist.  To date, you have had no further symptoms.  PAST MEDICAL HISTORY:  hypertension, hypercholesterolemia, pre-diabetes.  PRE-VACCINE MEDICATIONS:  losartan, HCTZ, amlodipine, Welchol, fenofibrate, fish oil.  POST-ER VISIT MEDICATIONS:  losartan, HCTZ, amlodipine, Welchol, fenofibrate, Eliquis.
ED to Hosp-Admission Discharged  10/27/2021 - 11/2/2021 (6 days)   TIA (transient ischemic attack)   #COVID-19 infection (initial positive date 10/27) -only symptoms were cough and rhinorrhea -Tested +10/27. Test was negative on 10/20 during previous admission. Patient was immunized with Pfizer x2 doses in April/May -Completed remdesivir  Continue dexamethasone (day 5/10)  -did not require supplemental oxygen during admission
Redness with swelling 7m by 6m oval warm to touch, Benadryl 1 tsp PO q hr
Each time I got an injection, the reactions became more intense. First dose, large welts on arm an intense itching. 2 dose, welts on both arms and itching for 24 hours. Booster dose on 11/1421 rash all over my body and the rash lasted almost a full week. I cannot get flu shots because they cause my tongue to swell up. haven't had a flu shot in 7/8 years.
client complained of dizziness after receiving 1st Pfizer Covid vaccine. Client alerted EMTs she was feeling dizzy and headache at 1330. Vitals at 1333: blood pressure 155/95, pulse 103, oxygen 98%. Per client dizziness 8/10, headache to occipital region 7/10. No medical history, medication or allergies. PHN arrived within 5 minutes. Upon arrival client sitting upright in chair, alert and oriented x4. Client denied blurry vision, chest pain, shortness of breath. At 1340 client able to transfer to anti-gravity chair with no assistance. EMT gave water. Vitals at 1342: blood pressure 144/91, pulse 105, oxygen 98%. Client stated feeling warm in face. PHN  asked client to lower mask. Client's face flushed, hives on neck and upper chest. Per client dizziness and nausea same. Client denied shortness of breath. Clinic offered client Benadryl, client accepted. Daughter present and would drive client home. Bendaryl 50mg IM given at 1344 on right deltoid.  1345 client stated itchy throat feeling, clinic assessed for swelling, client denied throat closing. Client speaking in full sentences. Vitals at 1352: blood pressure 132/86, pulse 91, oxygen 97%. Face flushed, hives on neck. Per client headache 6/10 and dizziness improving and only felt warmth in cheeks. Vitals at 1357: blood pressure 127/85, pulse 89, oxygen 98%. Per client headache resolved, dizziness 6/10, felt dry throat but no itchiness or shortness of breath, warmth in cheeks improving. Client face flushing improving, no hives in upper chest, hives on neck and improving. Clinic  gave client some water upon request, advised to take small sips. Client stated was able to swallow with no problem. Vitals at 1407: blood pressure 131/78, pulse 83, oxygen 98%. Per client dizziness, headache and warm feeling resolved. Client with redness in cheeks and neck. Vitals at 1414: blood pressure 130/82, pulse 95, oxygen 100%. Client cheeks and neck pink, no hives. Client denied feeling warm, dizzy, headache, shortness of breath. Per client feeling much better and was ready to home home and rest. PHN advised client to follow up with provider and gave ER precautions. Daughter would drive client home. Client left facility with steady gait at 1423.
A couple of minutes after TD administration, pt had a metallic taste in mouth.  This had been preceeded by a nerve sensation from right upper arm to right side of face.  The taste eventually decreased.  During a period of 30 minutes after IM injection, pt felt weak, laid down, legs felt shaky, right arm felt heavy, didn't feel well.  Upon sitting up, pt felt dizzy and feet felt tingly.  BP and pulse steady 112/60 and 76 all during this time.  Escorted to clinic due to continuing symptoms.
Patient received Johnson & Johnson (J&J) Janssen COVID 19 vaccination on 3/31/21. Follow up telephone call was done to patient to assess for warning signs of blood clots. Patient reports new onset of shortness of breath 3 days after receiving the J&J COVID 19 vaccination and severe headaches. Patient denies any other symptoms of abdominal pain, leg pain or swelling, backache, petechiae, or new or easy bruising. Patient was given the following recommendations to seek medical care at the nearest emergency department. Patient states he is going to make a medical appointment with his primary care doctor at a local clinic in the town he lives in. Patient was advised due to the symptoms he is experiencing that he should seek medical attention for the symptoms he is having due to the warning signs of a type of blood clot that is occurring in the J&J COVID 19 vaccination.
Severe pain in rt. arm and shoulder, went to E.R., PA couldn't diagnose what was wrong. Went to Dr. the next day, still in severe pain, couldn't move arm. Dr. prescribed steroids and antibiotic.
pt went unconscious when mom went to feed pt; mom stated that pt turned pale & blue around the lips; In ER pt was nl; pt found to have temp>101 in ER:
Pain, swelling, redness, warmth at site of injection right arm. Chills. Progressed to cellutites in right arm. Infection on right arm from pneumonia shot. Tenderness
Delayed type hypersensitivity reaction to aluminum component in Hepatitis A or B vaccine caused a subcutaneous nodule. patient had bump on left leg.
Information has been received from a pharmacist and the step daughter of a 64 yr old male with asthma. On 25Oct05, the pt was vaccinated with pneumococcal 23v polysaccharide vaccine (lot649988/0692P). On an unspecified date, the pt developed redness and swelling of the injection site arm. The pt was prescribed antibiotics. It was further reporter that the pt developed significant swelling, redness and pain from the top of his shoulder down past his elbow. The pt sought unspecified medical attention. At the time of this report, the outcome of the events were unk. Additional information has been requested.
On the first day around 4:00pm my arm swelled up all to my shoulder, under my arm, into my back and chest. I called the clinic where I received my vaccine and they said it was normal and to put ice on. I did put ice on it and it did not help. I went to bed and woke up around 6am with a fever  around 102 and I was soaking wet from sweating. I began throwing up and had green snot. I felt horrible all over. About 9am I called minute clinic again and told them what was going on and they said it was normal to take Tylenol, drink fluids, and rest. Day 3  and day 4 no improvement and called minute clinic again and they said its normal and to wait. Day 5 I went to care now because minute clinic would not help me. They gave me an Augmentin and methylprednisolone. The doctor there said it was an obvious allergic reaction. I now think I have thrush from taking the steroids.
This case was reported by a consumer and described the occurrence of facial palsy in a 71 year old male subject who was vaccinated with Fluarix for prophylaxis. The reporter is the daughter of the subject. A physician or other health care professional has not verified this report. The subject had no pre-existing medical conditions. There were no concurrent medications. On 15 October 2005 the subject received 1st dose of Fluarix in the right arm. On 19 October 2005, 4 days after vaccination with Fluarix, the subject experienced an ear ache. On 20 October 2005, the subject experienced facial paralysis. The subject "was taken to a doctor's office after (he) thought he had experienced a stroke." The subject was diagnosed with facial palsy and an ear infection. The subject was treated with steroids for facial palsy and antibiotics for ear infection. At the time of initial reporting, 21 October 2005, the events were ongoing. Comment: Facial palsy was assessed as medically serious by the manufacturer (OMIC).
The next day after receiving Spikevax, around 11pm, developed chills, lightheadness, dizziness, double vision, nausea and headache. The symptoms improved over time, however, has remained nauseous that comes and goes at the time of this entry
TC from pt, stating child had a rash on back area, 1 hour, post vax. Told to call MD. When RN called back, client to follow-up on condition. Parent denied rash ever present or TC made to RN; did no visit MD.
Patient got a flu shot. At the time of injection, she stated she had an electrifying shock/shooting pain that ran down her left side of the body. She did not mention this at the time of her vaccine appointment; she mentioned it today on 10-9-2023. She states she does not have that shooting pain or shock anymore;however, her arm still hurts when she lifts her arm up to 45 degree. She will check in with her provider.
received vaccine as usual. One hour later I began to itch. 3-4 hours later I noticed significant itching, splotchy rashes over body, heat, and incremental growth of rash as time progressed. By midnight I was covered top of feet to scalp, sans toe/fingernails, genitals, and mouth. Horrible itchy and slight heat remains however now not as red. Used Hydrocortizone 2%, Gold Bond eczema cream, and absorbine Jr. No history of allergies, so did not have any related meds in home. No respiratory issues. Site never red or warm. I have pictures documenting some of the past 24 hrs.   Fluzone UT7081KA, expires 6/30/2021, L deltoid <-- yesterday's flu shot information provided by occupational health at saint Mary's regional medical center employee
Patient reported having itching all over his body, a short period of difficulty breathing and trouble sleeping beginning on the evening of 10/7/10.  He stated the difficulty breathing was short and resolved that evening. The itching and trouble sleeping resolved by the morning of 10/10/10.
(5/30/18) Pt reports 2 days after getting vaccines listed below 6.1.18 that her left foot became swollen and red and very itchy. Pt states today 6/6/18 swelling and redness improved; still itchy.
headache, sore throat, cough, fever, chills, shortness of breath, body aches, chest congestion. starting on 10/16/21
Returned to clinic two days post TDAP and placement of TST c/o (L) deltoid up into shoulder & down to hand hurting, not tingling, hurting able to move thumb to fingers open & close fist raise arm. Site without redness but approximately 3" x 3" raised warm to touch area over deltoid.
Baby cosleeping with mom found in cardiorespiratory arrest by mom.  Nurse follow up on 07/12/04 states: "None."  Nurse follow up on 08/30/04 states: "SIDS."
4" x 3" reddened and hived area appeared <5 minutes after administration of vaccine. Reaction was localized to site of administration. Pt given Benadryl and cool pack and observed for 20 minutes. Reaction began to subside 15 minutes after administration of Benadryl. Child complained of itching prior to Benadryl, itching relieved by Benadryl.
Initial report received from a non-healthcare professional (patient's parent) on 23 SEPTEMBER 2013.  A 2-year-old male patient had received a fourth dose of DTap (lot number was not available, route of administration was not reported) in the thigh on 16 SEPTEMBER 2013. The patient had previously experienced "crying for days" after receiving DTap, RV, HIB and IPOL at two, four and six months of age and had intussusception". The patient was hospitalized. The patient had no illness at the time of vaccination. The patient had no known allergies. He was concomitantly on "Lebsen drops" twice daily. Prevacid 5mg twice daily, "Genulac" 10mg twice daily, Probiotics, Ter-Fair Biotic for children (Klare labs) and Betaine Hydrochloride.  On an unspecified date, 48 hours after vaccination, the patient began to cry, was holding stomach and had crampy pain in abdomen. The patient was not sleeping well. On an unspecified date, the patient had done blood work with normal result (list of labs were not available). Corrective treatments were not reported. At the time of this report, the patient was recovering from the event of abdominal pain. The outcome of event crying was unknown and the patient was not still sleeping well. Documents held by sender: none.
Concerningly patient had her first Moderna COVID-19 vaccination on 3/9/2021.  I actually saw her in the office on 3/12/2021 for low back pain.  She was having a hard time bearing weight and had fallen multiple times. This had started prior to her vaccine.  She reports that after the vaccine, approximately 2 to 3 days after she had the vaccine, she had sudden onset lower extremity weakness that was extreme.  This was acutely worse than when I saw her in the office.  She reports her lower legs were almost paralyzed and she was unable to walk.  She did not seek medical attention or contact my office regarding the symptoms.  Patient reports she was basically bedbound for 3 to 4 weeks and then symptoms very suddenly stopped.  She did talk to her cardiologist about that at her routine follow-up and they recommended she hold off on getting the second Moderna vaccine.  Her strength has recovered, she estimates she has approximately 60 to 70% of her lower extremity strength at this time.  She continues to have mild back pain however this has almost resolved as well.  Denies falls or trauma around the time of her pain and weakness.  Patient does report follow-up with her neurologist in the next few weeks and will discuss further with them
UrticariaPruritus Narrative Experienced pruritus and tenderness of injection site starting two days after the vaccination, persisted for 3 days. Denies associated rash, induration, erythema, warmth of area, hives, sloughing, swelling or other adverse effects. No therapies tried or applied.
shingles; Information has been received regarding a case in litigation, referring to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided. On 10-DEC-2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) as prescribed and/or administered by a pharmacist, for the long-term prevention of shingles and/or zoster-related conditions (strength, route, frequency, lot# and expiration date were not reported). On an unknown date, subsequent to the zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of the patient's zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of shingles was not reported. The reporter considered shingles to be related to zoster vaccine live (ZOSTAVAX).
Inadvertent administration of Moderna COVID-19 Vaccine to a 17 year old patient; A spontaneous report was received from a nurse concerning a 17-year-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced inadvertent administration of Moderna COVID-19 vaccine to a 17 year old patient.   The patient's medical history and concomitant product use were not provided.  On 29-Dec-2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 29-Dec-2020, the 17-year-old patient received the vaccine.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the event, inadvertent administration of Moderna COVID-19 vaccine to a 17 year old patient, was considered recovered on 29 Dec 2020.; Reporter's Comments: This case concerns a 17-year-old patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product administered to patient of inappropriate age without any associated adverse events.
injection site pain; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a elderly patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine at an unknown dose. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced injection site pain. The patient asked about how long does the injection site hurt. The patient also mention that was the worst shot I have ever got.
DIZZY; "JOINTS KILLED ME"; ACHY; This spontaneous report was received from a consumer and concerned a female patient of an unspecified age with an unknown race and unknown ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced achy, "joints killed me", and dizzy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the achy, "joints killed me" and dizzy was not reported. This report was non-serious.
Joint pain in thumbs, with limited bending and pain when bending thumb to grasp or even shake hands. Taking Ibuprofen and Asa po prn
Tested positive for Covid by Dr. Severe cough, running nose. tired, achy infection site
Red itchy swollen area at injection site.  This occurred a week after  I received the first shot.
GUILLAIN BARRE SYNDROME; HEADACHE; NAUSEA; VOMITING; This spontaneous report was received from literature: A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination. 2021 Aug 13; Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. 2021 November 19;  The objective of this study was to extensively review published literature regarding post-COVID-19 vaccination neurological complications and characterize neuroimaging findings from three case presentations for early diagnosis and treatment.  This report concerned a 60 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 01) (suspension for injection, route of administration, batch number and expiry were not reported) dose, start therapy date were not reported for 01 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced pain in her back and leg, nausea, vomiting, headache and diplopia. Diagnosis (on an unspecified date) was reported to be Guillain-Barre syndrome. Laboratory data (dates unspecified) included: Cerebrospinal fluid (CSF) protein was140 mg/dL, Glucose was normal, Magnetic resonance imaging spinal (Lumbar) demonstrated enhancement of the cauda equina, and Cell count was 9 cells/microL (9 nucleated cells/mm3). Treatment administered was Intravenous Immunoglobulin Therapy (IVIg). Time duration from COVID-19 vaccination to neurological symptom onset (latency) was 10 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from Guillain-Barre, nausea, vomiting and headache syndrome. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210837750.; Sender's Comments: V0: 20211230158-COVID-19 VACCINE AD26.COV2.S-Guillain Barre syndrome. This event is labeled and is therefore considered potentially related.
This spontaneous report as received from a consumer refers to 11 year old female patient (consumer's daughter). The patient's medical history included severe fever on an unspecified date to an unspecified spinal meningitis vaccine when she was 4 months old. On 06-NOV-2013, the patient was vaccinated with GARDASIL (dose, route of administration, lot#/batch# were not reported). No concomitant medications reported. On 09-NOV-2013, the patient experienced severe backache which began 4 days after the administration of the vaccine. On 12-NOV-2013, the patient experienced severe headache. It was also reported that she had a reaction on an unspecified date to an unspecified spinal meningitis vaccine when she was 4 months old and required hospitalization in an unspecified hospital, for "a couple of days"  on an unspecified date. There was no diagnostics studies performed. The outcome of severe headache and severe backache was reported as not recovered/not resolved. Additional information has been requested.
This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapy, drug and allergy history were not provided. On an unspecified date in September 2017, the patient was vaccinated with an improperly stored dose of PEDVAXHIB (strength, dose, frequency, dose number and administration route were not reported) lot number M010440, expiration date 09-DEC-2018, for prophylaxis. On an unspecified date in 2017, the vaccines were exposure to a temperature excursion; the data logger registered a temperature range between 47 Fahrenheit (F) and 77 F (54.6 F) for 2 hours. The previous temperature excursion registered was 47 F to 77 F (54.1 F) for 1 hour. No adverse effects were reported. Sender's Comments: US-009507513-1711USA009697: US-009507513-1711USA009695: US-009507513-1711USA009696.
AROUND 11:30AM ON 12/21 PT'S GIRLFRIEND REPORTS PT STARTED FEELING DIZZY, LIGHT-HEADED THEN FAINTED. CONCERNS FROM GIRLFRIEND OF POSSIBLE SEIZURE.